Validação de método analítico indicativo de estabilidade para doseamento de nevirapina em matéria-prima e comprimido por cromatografia líquida de alta eficiência
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Tipo de documento: | Trabalho de conclusão de curso |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/184748 |
Resumo: | Nevirapine belongs to a class of non-nucleoside reverse transcriptase inhibitor. In Brazil, this drug is available as 200 mg tablet and 10 mg mL-1 oral suspension. In Brazilian Pharmacopoeia 5th Edition there is not a monograph related to the drug nevirapine in any of its pharmaceutical forms and there are methods with different parameters described in The United States Pharmacopeial Convention (USP 38). Therefore, the aim of this study was to evaluate and optimize a single analytical HPLC method to detect and quantify raw material and tablets containing this drug. The mobile phase consisted of acetonitrile and water at a flow rate of 1.0 mL min-1 and wavelength at 220 nm. The analytical method was validated according to the official guidelines. The linearity was obtained over the concentration range from 10 to 80 mg mL-1 (r2 = 0.9987) and analysis of variance indicated linear regression without deviation from linearity (α = 5%). Adequate results were found for repeatability, intra-day precision (< 2% RSD), accuracy and robustness. Degradation studies combined with purity of peak analysis were used to evaluate the stability-indicating capability of the method. |
id |
UFRGS-2_512d9e26a9dc5f11f6cfb6d33cc620c8 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/184748 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Leites, Fernanda IzaguirreSchapoval, Elfrides Eva SchermanCordenonsi, Leticia Malgarim2018-11-17T03:12:02Z2016http://hdl.handle.net/10183/184748001020638Nevirapine belongs to a class of non-nucleoside reverse transcriptase inhibitor. In Brazil, this drug is available as 200 mg tablet and 10 mg mL-1 oral suspension. In Brazilian Pharmacopoeia 5th Edition there is not a monograph related to the drug nevirapine in any of its pharmaceutical forms and there are methods with different parameters described in The United States Pharmacopeial Convention (USP 38). Therefore, the aim of this study was to evaluate and optimize a single analytical HPLC method to detect and quantify raw material and tablets containing this drug. The mobile phase consisted of acetonitrile and water at a flow rate of 1.0 mL min-1 and wavelength at 220 nm. The analytical method was validated according to the official guidelines. The linearity was obtained over the concentration range from 10 to 80 mg mL-1 (r2 = 0.9987) and analysis of variance indicated linear regression without deviation from linearity (α = 5%). Adequate results were found for repeatability, intra-day precision (< 2% RSD), accuracy and robustness. Degradation studies combined with purity of peak analysis were used to evaluate the stability-indicating capability of the method.application/pdfporFarmáciaNevirapineHPLCValidationValidação de método analítico indicativo de estabilidade para doseamento de nevirapina em matéria-prima e comprimido por cromatografia líquida de alta eficiênciaValidation of analytical method stability indicating for nevirapine assay in raw material and tablet by high performance liquid chromatography info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisUniversidade Federal do Rio Grande do SulFaculdade de FarmáciaPorto Alegre, BR-RS2016Farmáciagraduaçãoinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001020638.pdf.txt001020638.pdf.txtExtracted Texttext/plain43881http://www.lume.ufrgs.br/bitstream/10183/184748/2/001020638.pdf.txtf82fb1e7ab8e6d847d368a6878cf5fdaMD52ORIGINAL001020638.pdfTexto completoapplication/pdf860030http://www.lume.ufrgs.br/bitstream/10183/184748/1/001020638.pdfe1b703cc54e20ea08ede2ecd5c2c7436MD5110183/1847482018-11-18 02:41:31.084019oai:www.lume.ufrgs.br:10183/184748Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2018-11-18T04:41:31Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Validação de método analítico indicativo de estabilidade para doseamento de nevirapina em matéria-prima e comprimido por cromatografia líquida de alta eficiência |
dc.title.alternative.en.fl_str_mv |
Validation of analytical method stability indicating for nevirapine assay in raw material and tablet by high performance liquid chromatography |
title |
Validação de método analítico indicativo de estabilidade para doseamento de nevirapina em matéria-prima e comprimido por cromatografia líquida de alta eficiência |
spellingShingle |
Validação de método analítico indicativo de estabilidade para doseamento de nevirapina em matéria-prima e comprimido por cromatografia líquida de alta eficiência Leites, Fernanda Izaguirre Farmácia Nevirapine HPLC Validation |
title_short |
Validação de método analítico indicativo de estabilidade para doseamento de nevirapina em matéria-prima e comprimido por cromatografia líquida de alta eficiência |
title_full |
Validação de método analítico indicativo de estabilidade para doseamento de nevirapina em matéria-prima e comprimido por cromatografia líquida de alta eficiência |
title_fullStr |
Validação de método analítico indicativo de estabilidade para doseamento de nevirapina em matéria-prima e comprimido por cromatografia líquida de alta eficiência |
title_full_unstemmed |
Validação de método analítico indicativo de estabilidade para doseamento de nevirapina em matéria-prima e comprimido por cromatografia líquida de alta eficiência |
title_sort |
Validação de método analítico indicativo de estabilidade para doseamento de nevirapina em matéria-prima e comprimido por cromatografia líquida de alta eficiência |
author |
Leites, Fernanda Izaguirre |
author_facet |
Leites, Fernanda Izaguirre |
author_role |
author |
dc.contributor.author.fl_str_mv |
Leites, Fernanda Izaguirre |
dc.contributor.advisor1.fl_str_mv |
Schapoval, Elfrides Eva Scherman |
dc.contributor.advisor-co1.fl_str_mv |
Cordenonsi, Leticia Malgarim |
contributor_str_mv |
Schapoval, Elfrides Eva Scherman Cordenonsi, Leticia Malgarim |
dc.subject.por.fl_str_mv |
Farmácia |
topic |
Farmácia Nevirapine HPLC Validation |
dc.subject.eng.fl_str_mv |
Nevirapine HPLC Validation |
description |
Nevirapine belongs to a class of non-nucleoside reverse transcriptase inhibitor. In Brazil, this drug is available as 200 mg tablet and 10 mg mL-1 oral suspension. In Brazilian Pharmacopoeia 5th Edition there is not a monograph related to the drug nevirapine in any of its pharmaceutical forms and there are methods with different parameters described in The United States Pharmacopeial Convention (USP 38). Therefore, the aim of this study was to evaluate and optimize a single analytical HPLC method to detect and quantify raw material and tablets containing this drug. The mobile phase consisted of acetonitrile and water at a flow rate of 1.0 mL min-1 and wavelength at 220 nm. The analytical method was validated according to the official guidelines. The linearity was obtained over the concentration range from 10 to 80 mg mL-1 (r2 = 0.9987) and analysis of variance indicated linear regression without deviation from linearity (α = 5%). Adequate results were found for repeatability, intra-day precision (< 2% RSD), accuracy and robustness. Degradation studies combined with purity of peak analysis were used to evaluate the stability-indicating capability of the method. |
publishDate |
2016 |
dc.date.issued.fl_str_mv |
2016 |
dc.date.accessioned.fl_str_mv |
2018-11-17T03:12:02Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/184748 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001020638 |
url |
http://hdl.handle.net/10183/184748 |
identifier_str_mv |
001020638 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/184748/2/001020638.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/184748/1/001020638.pdf |
bitstream.checksum.fl_str_mv |
f82fb1e7ab8e6d847d368a6878cf5fda e1b703cc54e20ea08ede2ecd5c2c7436 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
lume@ufrgs.br |
_version_ |
1817724654759968768 |